Newly diagnosed enhancing lesions: Steroid initiation may impede diagnosis of lymphoma involving the central nervous system.
Document Type
Article
Publication Date
11-1-2020
Publication Title
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Abstract
Establishing the pathologic diagnosis of central nervous system (CNS) lymphoma can be challenging, yet management of this potentially curable disease depends heavily on it. One avoidable impediment to obtaining an accurate and timely diagnosis is the pre-operative administration of steroids, which causes tumor involution and prevents appropriate sampling of viable tissue. We discuss a case of primary CNS lymphoma that highlights the evolution of the disease and the attempts to establish a diagnosis in the setting of prior administration of corticosteroids. Familiarity with these clinical scenarios will help others avoid delays in patient care that results from delayed diagnosis.
Volume
81
First Page
61
Last Page
64
Recommended Citation
Kam KL, Brooker SM, Mao Q, Barnea Slonim L, Yaseen NR, Brat DJ, Sonabend AM, Lukas RV. Newly diagnosed enhancing lesions: Steroid initiation may impede diagnosis of lymphoma involving the central nervous system. J Clin Neurosci. 2020 Nov;81:61-64. doi: 10.1016/j.jocn.2020.09.014. Epub 2020 Sep 29. PMID: 33222970.
DOI
10.1016/j.jocn.2020.09.014
ISSN
1532-2653
PubMed ID
33222970